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Fibrocalculous pancreatic diabetes (FCPD) is a secondary cause of diabetes due to chronic pancreatitis. Since the
N34S variant of the SPINK1 trypsin inhibitor gene has been found to partially account for genetic susceptibility
to chronic pancreatitis, we used a family-based and case-control approach in two separate ethnic groups from the
Indian subcontinent, to determine whether N34S was associated with susceptibility to FCPD. Clear excess trans-
mission of SPINK1 N34S to the probands with FCPD in 69 Bangladeshi families was observed ( ; 20P ! .0001
transmissions and 2 nontransmissions). In the total study group (Bangladeshi and southern Indian) theN34S variant
was present in 33% of 180 subjects with FCPD, 4.4% of 861 nondiabetic subjects (odds ratio 10.8; P ! .0001
compared with FCPD), 3.7% of 219 subjects with type 2 diabetes, and 10.6% of 354 subjects with early-onset
diabetes (aged !30 years) ( compared with the ethnically matched control group). These results suggestPp .02
that the N34S variant of SPINK1 is a susceptibility gene for FCPD in the Indian subcontinent, although, by itself,
it is not sufficient to cause disease.
Fibrocalculous pancreatic diabetes (FCPD) has been clas-
sified by the World Health Organization as a secondary
cause of diabetes due to disease of the exocrine pancreas
(Alberti and Zimmet 1998). It is a condition in which, in
addition to diabetes being present, there is also evidence
of chronic pancreatitis of unknown origin with large in-
traductal pancreatic stones (Mohan et al. 1998). Patients
frequently have a low body mass and a history of chronic
abdominal pain and require insulin treatment, although,
unlike in type 1 diabetes (T1D), they are not prone to
ketosis. We have hypothesized that FCPD is likely to be
a multifactorial disease, with genetic and environmental
components to both the diabetes and chronic pancreatitis.
In support of a genetic background to FCPD, we have
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demonstrated familial clustering of the disease (Mohan et
al. 1989). More specifically, we have demonstrated as-
sociations between FCPD and human leukocyte antigen
(HLA) genotype in subjects from southern India and
Bangladesh, which revealed both similarities to and dif-
ferences from T1D (Kambo et al. 1989; Chowdhury et
al. 2002). Other groups have also demonstrated HLA
associations with FCPD, although the disease-associated
alleles are not always consistent between studies (Sanjeevi
et al. 1999). We have also found an association between
the insulin gene hypervariable region and FCPD in south-
ern Indian but not in Bangladeshi subjects (Kambo et al.
1989; Chowdhury et al. 2002).
Recently, there has been rapid progress in understand-
ing the genetic basis of hereditary and idiopathic pan-
creatitis (Whitcomb 1999, 2000, 2002; Truninger et al.
2001) with the identification of mutations in the cation-
ic trypsinogen gene (Whitcomb et al. 1996; Gorry et al.
1997; Teich et al. 2002), the cystic fibrosis transmembrane
conductance regulator (CFTR) (Cohn et al. 1998; Sharer
et al. 1998; Ockenga et al. 2000; Noone et al. 2001), and
the serine protease inhibitor, Kazal type 1 (SPINK1 [MIM
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Table 1
Frequency of the SPINK1 N34S Variant in the Various Study Groups
GROUP (n)
SPINK1 GENOTYPE FREQUENCY (n)
P VALUEa
Homozygote
Wild-Type
Heterozygote
N34S
Homozygote
N34S
Bangladeshi:
Probands with FCPD (69) .739 (51) .217 (15) .043 (3) !.0001
Other FCPD (43) .581 (25) .279 (12) .140 (6) !.0001
Nondiabeticb (393) .944 (371) .053 (21) .003 (1)
Under-30 diabetes (354) .893 (316) .099 (35) .008 (3) .02
Sylheti Nondiabeticc (156) .968 (151) .032 (5) 0
Sylheti T2D (142) .965 (137) .035 (5) 0 NS
South Indian:
FCPD (68) .647 (44) .265 (18) .088 (6) !.0001
Nondiabetic (312)b .965 (301) .032 (10) .003 (1)
Impaired fasting glucose/IGT (56) .964 (54) .036 (2) 0 NS
T2D (77) .961 (74) .039 (3) 0 NS
a For comparison with nondiabetic group. NS p not significant.
b Defined by fasting blood glucose !6 mmol/liter.
c Defined by either a random or fasting blood glucose !6 mmol/liter.
167790]) genes (Chen et al. 2000; Pfu¨tzer et al. 2000,
2002; Witt et al. 2000; Threadgold et al. 2002), all as-
sociated with disease. We have already excluded common
mutations of the cationic trypsinogen gene in FCPD (Rossi
et al. 1998; Hassan et al. 2000). In contrast, recently
published data have suggested that the SPINK1 N34S
variant may be a cause of FCPD (Rossi et al. 2001; Chan-
dak et al. 2002). The N34S variant was found in 7 of 24
patients with FCPD and in 16 of 44 patients with tropical
pancreatitis without diabetes (TCP) living in India (Chan-
dak et al. 2002). In a pilot study of Bangladeshi subjects,
theN34S variant was present in five of eight patients with
FCPD but was absent in four patients with TCP and in
four control individuals (Rossi et al. 2001). More recent
data analyzing a further 140 Bangladeshi subjects (14
patients with FCPD, 11 patients with TCP, 43 young pa-
tients with T2D, and 72 control individuals) support the
pilot data for FCPD (Schneider et al., in press).
The purpose of the present study was multifold. First,
we used a family-based study of subjects from Bangla-
desh to test for an association between the SPINK1
N34S variant and either FCPD or early-onset diabetes.
Second, we tested for an interaction between SPINK1
and either HLA-DQB genotype or the insulin-gene hy-
pervariable region, in the family resources. Since we
found an association between FCPD susceptibility and
the SPINK1 N34S variant, we then proceeded to deter-
mine the frequency of this variant in two further ethnic
groups from the Indian subcontinent, in order to rep-
licate the original study and to investigate a possible
association with type 2 diabetes (T2D). No patients are
duplicated between this study and the other pilot data
(Rossi et al. 1998; Schneider et al., in press).
We used a PCR-RFLP assay (endonuclease TaaI) to
identify SPINK1 N34S (Plendl et al. 2001) in 69 families
from Bangladesh, which were included in the study if
they met the following two criteria: (1) an index case
individual with FCPD was present and (2) both parents
of the index case individual were available for study.
Twenty-six percent of the probands with FCPD (mean
 SD age at onset 18.8  4.7 years; mean  SD BMI
15.9  2.83 kg/m2) possessed the variant. There was
clear excess transmission of the variant from the parents
to the index case individual in the trios ( ); 20P ! .0001
transmissions and 2 nontransmissions. The multifacto-
rial nature of FCPD is supported by the observation that,
although parents carried the SPINK1 N34S variant,
none had FCPD on the basis of clinical criteria.
In our previous study of the same families (Chowdhury
et al. 2002), there was a significantly decreased trans-
mission of HLA-DQB1*0202 from the parents to the in-
dex case individual. It could therefore be postulated that
HLA-DQB1*0202 might protect a subject from FCPD in
the presence of the disease-associated N34S variant. To
address this question, we compared phenotype frequen-
cies in the parents according to the presence or absence
of N34S and DQB1*0202; no difference in distribution
was found ( ). We have also observed increasedPp .86
transmission of the HLA marker TNFc and HLA-
DQB1*0302 (Chowdhury et al. 2002) to the probands
with FCPD. No gene-to-gene interaction in the index case
individuals with FCPD was found between SPINK1 and
either of two major histocompatibility complex (MHC)
markers on chromosome 6 (TNFc, ; and HLA-Pp .70
DQB1*0302, ). Furthermore, no interaction be-Pp 1.0
tween SPINK1 and alleles defined by HphI of the insulin
gene ( ) was found. This would suggest that, inPp .68
an individual with FCPD, the known genetic factors pre-
disposing to either chronic pancreatitis or diabetes are
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Figure 1 Southern Indian family in which each individual geno-
typed is homozygous for the SPINK1 N34S variant. A symbol with a
line through it denotes a deceased individual, an unshaded symbol de-
notes an unaffected individual, a black symbol denotes an individual
with FCPD, a gray symbol denotes an individual with TCP, and a di-
agonally striped symbol denotes an individual with IGT. SPINK1 ge-
notypes are given under the symbols; 2p variant. The wild-type allele
was not detected in genotyped individuals from this family.
acting independently of each other, rather than in a syn-
ergistic manner.
The frequencies of the N34S variant in the other study
groups are presented in table 1. This variant was present
in 41.9% of the additional unrelated Bangladeshi subjects
with FCPD (mean age at onset of diabetes 20.4 5.7
years; mean BMI kg/m2), compared with17.0 3.33
5.6% of control individuals (mean age years;22.8 4.8
mean BMI kg/m2) ( for genotype20.0 3.4 P ! .0001
differences). In southern Indian subjectswith FCPD(mean
age at onset of diabetes years; mean BMI28.0 7.9
kg/m2), the variant was present in 35.3% of19.4 3.7
patients, compared with 3.5% of control individuals
(mean age years; mean BMI kg/42.8 12.7 22.0 4.3
m2) ( ), suggesting the SPINK1 N34S predis-P ! .0001
poses to FCPD in subjects from both southern India and
Bangladesh. Five southern Indian families were also
screened (three families had more than one member with
FCPD, and two had one member with FCPD and at least
one other with T2D). The variant was present in only
one family. In this consanguineous family (fig. 1) the
father had FCPD and the mother had idiopathic TCP;
both were homozygous for the N34S variant, as were all
six children (two with FCPD, one with TCP, one with
impaired glucose tolerance [IGT], and two without
diabetes).
To further investigate a possible association between
N34S and diabetes, we investigated several additional
resources (table 1). The first group ( ) consistednp 354
of Bangladeshi subjects presenting with diabetes before
the age of 30 years (subsequently referred to as “under-
30 diabetes” [mean age at onset years; mean18.7 6.2
BMI kg/m2]) at the Bangladesh Institute of18.3 5.1
Research and Rehabilitation in Diabetes, Endocrine and
Metabolic Disorders (BIRDEM) clinic, none of whom
had either FCPD (normal abdominal x-ray and no his-
tory of severe abdominal pain) or T1D (defined by an
acute onset of disease with ketosis or insulin depen-
dency). The N34S variant was present in 10.9% of sub-
jects in the under-30 diabetes group ( comparedPp .02
with the control group). The increased frequency of the
variant in this group is likely to reflect the presence of
subjects with diabetes and subclinical chronic pancrea-
titis. A different study design and further genetic and
immunological investigations are required to investigate
this further.
The second cohort we studied were Bangladeshi sub-
jects from Sylhet, ascertained either from a diabetes clinic
at the Royal London Hospital, London, or from a cor-
onary heart disease study in East London. In subjects from
Sylhet with T2D (mean age at onset of diabetes 44.7
years; mean BMI kg/m2), the frequency10.0 26.5 3.4
of N34S (3.5%) was no different than in ethnically
matched control individuals (mean age 41.5 10.4
years; mean BMI kg/m2) ( ). Similarly,26.9 9.7 Pp 1
in the third cohort of southern Indian subjects (Rama-
chandran et al. 1992), the frequencies of either IGT (mean
age years; mean BMI kg/m2)47.9 12.6 23.4 4.2
(3.6%) or T2D (mean age years; BMI53.6 10.7
kg/m2) (3.9%) was no different than that in23.8 3.2
control individuals (mean age years; mean42.8 12.7
BMI kg/m2) (3.5%) ( ). It is, therefore,23.4 4.1 Pp .94
highly unlikely that an association exists between the
SPINK1 N34S variant and the more common forms of
T2D or IGT.
There is overwhelming evidence that the SPINK1
N34S variant predisposes to chronic pancreatitis, since
it is present in 13%–40% of patients with idiopathic
chronic pancreatitis (Truninger et al. 2001; Witt 2002).
SPINK1 is a pancreatic secretory trypsin inhibitor, se-
creted from the pancreatic acinar cells into the pancreatic
juice, that prevents premature activation of zymogens
within the pancreas and pancreatic duct. Functional
studies on theN34S variant have not yet been published,
but it is likely to be of functional significance because
of its location near the reactive lysine-isoleucine site of
SPINK1 (Threadgold et al. 2002); furthermore, struc-
tural modeling has revealed several possible pathological
mechanisms for theN34Smutation (Pfu¨tzer et al. 2000).
In one of the earliest publications to indicate the im-
portance of SPINK1 in chronic pancreatitis, a clear ex-
cess transmission of SPINK1 variants to affected subjects
( in 29 informative transmissions), similar toP ! .0001
what we have observed for FCPD (Witt et al. 2000),
was found.
In many studies of non-Asian subjects, the frequency
of N34S has been 1% in control subjects (Chen et al.
2000; Pfu¨tzer et al. 2000; Witt et al. 2000; Threadgold
et al. 2002). In people without FCPD from the Indian
subcontinent, we have found the variant in 38 of 861
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(4.4%; range 3.2%–5.6%) nondiabetic subjects, with no
heterogeneity between ethnic groups ( ). Fur-Pp .54
thermore, a prevalence of 3% has been reported in a
control group from Hyderabad, India (Chandak et al.
2002). Although the frequency appears higher than in
non-Asian subjects, in a recently reported study in sub-
jects from Leeds, United Kingdom, the frequency was
4% (4/100) (Threadgold et al. 2002). However, these
control subjects were ascertained as healthy blood do-
nors and the ethnic group was not reported, and it is
known that Leeds has a large South Asian community.
It therefore remains to be determined whether the fre-
quency of N34S is higher in South Asians and whether
this may, in part, account for the comparatively higher
frequency of FCPD in this ethnic group.
In conclusion, we found a striking association, using
family-based and case-control methods, between N34S
and FCPD, with the variant being present in 33% of
180 subjects with FCPD, compared with 4.4% of 861
subjects without diabetes (odds ratio 10.8; 95% CI 6.9–
17.0). These studies demonstrate that SPINK1 is an im-
portant gene for FCPD susceptibility, although, by itself,
it is not sufficient for full expression of the disease. This
finding is very similar to that observed in idiopathic pan-
creatitis. Our data also emphasize the importance of
other environmental and genetic factors that are re-
quired for the full expression of FCPD.
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